Company intelligence / Profile preview

Wave Neuroscience

Newport Beach, California, USAwaveneuro.com ↗

Ownership: Private
Development stage: Commercial

Overview

Wave Neuroscience’s MeRT® technology is FDA-cleared for certain uses, with over 30,000 patients treated. The company reports significant improvements in symptoms of PTSD, TBI, depression, anxiety, and other neurological conditions based on real-world outcomes from its Braincare™ platform. No formal published pivotal clinical trial data was cited in the search results.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapyDigital health platform
Industry: Therapeutic Medical Devices

Partnerships

Collective Health

Beyond the preview

Go deeper on Wave Neuroscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wave Neuroscience.

Explore the full profile